WFRF:(Stenke A.)
Search: WFRF:(Stenke A.) > Nilotinib versus im...
- 17 of 50
- Previous record
- Next record
- To hitlist
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
- Kantarjian, HM (author)
- Hochhaus, A (author)
- Saglio, G (author)
- show more...
- De Souza, C (author)
- Flinn, IW (author)
- Goh, YT (author)
- Rosti, G (author)
- Nakamae, H (author)
- Gallagher, NJ (author)
- Hoenekopp, A (author)
- Blakesley, RE (author)
- Larson, RA (author)
- Hughes, TP (author)
- show less...
- (creator_code:org_t)
- 2011
- 2011
- English.
- In: The Lancet. Oncology. - 1474-5488. ; 12:9, s. 841-851
- Journal article (peer-reviewed)
Subject headings
Close
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- The Lancet. Oncology (Search for host publication in LIBRIS)
To the university's database
- 17 of 50
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Kantarjian, HM
- Hochhaus, A
- Saglio, G
- De Souza, C
- Flinn, IW
- Stenke, L
- show more...
- Goh, YT
- Rosti, G
- Nakamae, H
- Gallagher, NJ
- Hoenekopp, A
- Blakesley, RE
- Larson, RA
- Hughes, TP
- show less...
- Articles in the publication
- The Lancet. Onco ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
